Page last updated: 2024-11-02

oxprenolol and Carcinoid Tumor

oxprenolol has been researched along with Carcinoid Tumor in 1 studies

Oxprenolol: A beta-adrenergic antagonist used in the treatment of hypertension, angina pectoris, arrhythmias, and anxiety.

Carcinoid Tumor: A usually small, slow-growing neoplasm composed of islands of rounded, oxyphilic, or spindle-shaped cells of medium size, with moderately small vesicular nuclei, and covered by intact mucosa with a yellow cut surface. The tumor can occur anywhere in the gastrointestinal tract (and in the lungs and other sites); approximately 90% arise in the appendix. It is now established that these tumors are of neuroendocrine origin and derive from a primitive stem cell. (From Stedman, 25th ed & Holland et al., Cancer Medicine, 3d ed, p1182)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
John, VA1
Monk, JP1
Dorhofer, G1

Other Studies

1 other study available for oxprenolol and Carcinoid Tumor

ArticleYear
Interference of an oxprenolol metabolite with screening tests for 5-hydroxyindole in urine.
    Clinical chemistry, 1983, Volume: 29, Issue:4

    Topics: Carcinoid Tumor; False Positive Reactions; Humans; Indoles; Oxprenolol

1983